The role of CDK4/6 inhibitors

Date 17 November 2017
Event ESMO Asia 2017 Congress
Session Optimal management of ER+ and HER-2 negative patients
Topics Anti-Cancer Agents & Biologic Therapy
Breast Cancer
Presenter Shigehira Saji
Authors S. Saji
  • -, Fukushima Medical University, 960-1295 - Fukushima/JP